What Should All Physicians Know About Endovascular Stroke Care?

December 4, 2020
Endovascular stroke care is the criterion standard for LVO treatment, yet not everyone is fluent with data and techniques.  
0 Comments

Emergency Nursing Assessments, the NIHSS and Pitfalls in Identifying Acute Stroke Patients. How Do You Do It, and Do It Well?

December 4, 2020
Nurses in the emergency setting are the key to stroke patient progression. From first point of assessment and triage, ED nurses set the standard. 
0 Comments

What Pitfalls Do Clinicians Face In Understanding Statistics In Acute Stroke Trials?

December 4, 2020
Statistics can illuminate or obfuscate. Clinicians need to understand acute stroke trial data and statistics in meaningful ways, but challenges abound.
1 Comments

What Was Missing From the NINDS Trial?

December 4, 2020
The NINDS trial was the seminal study of IV-tPA in the treatment of acute stroke. Yet controversy still exists around the trial methodology and the interpretation of the data. Was anything missing from NINDS? Does it still resonate nearly 25 years later?
0 Comments

Mobile Stroke Units - Linking Ultra Early Care and Outcomes

December 2, 2020
Imagine a mobile stroke unit, with a CT scanner, arriving to care for stroke patients at the first point of medical contact. What are the possibilities and what are the data?
0 Comments
RSS
First123456810
Categories
More Entries

Dec 4

IV tPA for Acute Strokes in Patients with COVID - What Does the Limited Evidence Mean?

Brian Gibler posted on 12/4/2020

 

The incidence of acute stroke in COVID-19 patients occurs at a rate that is at least 7 times greater than the general population. Controversy about the safety and efficacy of IV-tPA remains.

Dr. Matthew Smith, a fellow in neurocritical care and endovascular neurointervention presents key data and recommendations regarding the treatment of acute stroke in patients with COVID. Addressing the initial data from the early days of the pandemic and the newer data released, Dr. Smith guides the learner through an assessment of the efficacy and safety of IV-rtPA in the treatment of acute strokes in the era of COVID.

0 Comments
Tweet Share
Please login or register to post comments.
STAY CONNECTED
Let’s expand your stroke education network. Follow us on Twitter to get the latest updates about stroke education and stay up-to-date on hot topics in stroke care.
@stroke_journey
ABOUT THE STROKE JOURNEY
The Stroke Journey is an initiative developed by The National Stroke Education Center (NSEC) that strives to be the premier source of educational information for the diagnosis and treatment of stroke in the United States. NSEC extends the world-class educational expertise of the University of Cincinnati Department of Emergency Medicine and its partners via a variety of traditional and digital resources. NSEC and The Stroke Journey are dedicated to providing outstanding stroke education with timely material that mirrors the real-time changes in the medical education and stroke care landscape.
OUR PARTNERS
The Stroke Journey is a collaboration between the NSEC, EMCREG-International, and MedEd On The Go. Together we are committed to providing high-quality stroke education for healthcare professionals.
NSEC Sponsor Logo
EMREG Sponsor Logo
MedEd Sponsor Logo
Copyright 2024 The Stroke Journey | Privacy Policy | Terms of Use | Help & Support
Copyright 2024 The Stroke Journey
Privacy Policy | Terms of Use | Help & Support
Powered by MedEdOTG.com